Aldeyra Therapeutics

(NASDAQ) ALDX

Current Price$1.54

Market Cap$92.89M

Since IPO (2014)-78%

5 Year-87%

1 Year-36%

1 Month-14%

Aldeyra Therapeutics Financials at a Glance

Market Cap

$92.89M

Revenue (TTM)

$0.00

Net Income (TTM)

$27.37M

EPS (TTM)

$-0.46

P/E Ratio

-3.38

Dividend

$0.00

Beta (Volatility)

1.80 (High)

Dividend

$0.00

Beta (Volatility)

1.80 (High)

Price

$1.54

Volume

38,033

Open

$1.57

Price

$1.54

Volume

38,033

Open

$1.57

Previous Close

$1.54

Daily Range

$1.54 - $1.57

52-Week Range

$1.07 - $6.17

Dividend

$0.00

Beta (Volatility)

1.80 (High)

Price

$1.54

Volume

38,033

Open

$1.57

Previous Close

$1.54

Daily Range

$1.54 - $1.57

52-Week Range

$1.07 - $6.17

ALDX News

ALDX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aldeyra Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Todd C. Brady, MD, PhD

Website

www.aldeyra.com

Headquarters

Lexington, MA 02421, US

ALDX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-52%

Return on Capital

-0%

Return on Assets

-0%

Earnings Yield

-29.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$92.89M

Shares Outstanding

60.32M

Volume

38.03K

Avg. Volume

3.10M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$35.27M

EBITDA

$31.69M

Operating Cash Flow

$33.35T

Capital Expenditure

$0.00

Free Cash Flow

$33.35T

Cash & ST Invst.

$70.04M

Total Debt

$15.53M

Aldeyra Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$66.60K

N/A

Gross Margin

0.00%

N/A

Market Cap

$92.89M

N/A

Market Cap/Employee

$10.32M

N/A

Employees

N/A

Net Income

$3.45M

+65.2%

EBITDA

$3.48M

+62.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$49.49T

+66436443.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$15.51T

+6075290686.5%

Return on Assets

-0.00%

N/A

Return on Invested Capital

-0.00%

N/A

Free Cash Flow

$5.11M

+59.0%

Operating Cash Flow

$5.11M

+59.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

GNLXGenelux Corporation

GNLXGenelux Corporation$2.80-1.75%

MREOMereo BioPharma Group plc

MREOMereo BioPharma Group plc$0.24+0.25%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$5.77-7.38%

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.82+1.81%

AMRNAmarin Corporation plc

AMRNAmarin Corporation plc$14.05-0.07%

CLLSCellectis S.A.

CLLSCellectis S.A.$3.63-5.71%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$8.70+1.87%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.67-0.01%

POETPoet Technologies

POETPoet Technologies$13.07-0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.79-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$72.93-0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$44.37+0.02%

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF

NOWLGraniteShares ETF Trust - GraniteShares 2x Long Now Daily ETF$5.02-0.03%

ONDSOndas

ONDSOndas$9.13-0.06%

Questions About ALDX

What is the current price of Aldeyra Therapeutics?

Aldeyra Therapeutics is trading at $1.55 per share.

What is the 52-week range for Aldeyra Therapeutics?

Over the past 52 weeks, Aldeyra Therapeutics has traded between $1.07 and $6.18.

How much debt does Aldeyra Therapeutics have?

As of the most recent reporting period, Aldeyra Therapeutics reported total debt of $15.51M.

How much cash does Aldeyra Therapeutics have on hand?

Aldeyra Therapeutics reported $65.00M in cash and cash equivalents in its most recent financial results.

What is Aldeyra Therapeutics’s dividend yield?

Aldeyra Therapeutics does not currently have a dividend yield.

Aldeyra Therapeutics

Aldeyra Therapeutics Financials at a Glance

ALDX News

Why Aldeyra Therapeutics Stock Is Sinking Today

Why Aldeyra Therapeutics Stock Is Soaring Today

Why Aldeyra Therapeutics Stock Is Jumping Today

Why Aldeyra Therapeutics Stock Soared Today

Here's Why Aldeyra Therapeutics Stock Soared as Much as 79.1% Today

ALDX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aldeyra Therapeutics

ALDX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aldeyra Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALDX

What is the current price of Aldeyra Therapeutics?

What is the 52-week range for Aldeyra Therapeutics?

How much debt does Aldeyra Therapeutics have?

How much cash does Aldeyra Therapeutics have on hand?

What is Aldeyra Therapeutics’s dividend yield?

Premium Investing Services